Materialise CEO Calls for Common Approach in Measuring Clinical Evidence for Medical 3D Printing

Materialise CEO Calls for Common Approach in Measuring Clinical Evidence for Medical 3D Printing (press release)
For more... read my interview with Materialize CEO
Read list of 3D Printers in Orthopedics

CEO states that an evidence-based approach is necessary for medical 3D printing to gain the regulatory acceptance needed to be able to help more patients and save lives.
Orlando, Florida – May 5, 2016. Fried Vancraen, CEO of Materialise NV (Nasdaq: MTLS), the leading provider of Additive Manufacturing software and sophisticated 3D Printing solutions in the medical and industrial markets, c...